A-101 Vehicle

DRUG2 trials

Sponsors

Aclaris Therapeutics, Inc.

Conditions

Seborrheic KeratosisSeborrheic Keratosis (SK)

Phase 1

Study of Safety, Tolerability and Effectiveness of A-101 in Subjects With Seborrheic Keratosis

CompletedNCT01986920

Aclaris Therapeutics, Inc.Seborrheic Keratosis (SK)

Start: 2013-10-22End: 2014-02-25Updated: 2018-12-11

Phase 2

Dose-Response Profile of A-101 in Subjects With Seborrheic Keratosis

CompletedNCT02160626

Aclaris Therapeutics, Inc.Seborrheic Keratosis

Start: 2014-06-30End: 2014-12-31Updated: 2019-01-03